Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review

Postprandial Hyperglycemia Is a Better Predictor of the Progression of Diabetic Retinopathy Than HbA1c in Japanese Type 2 Diabetic Patients

  1. Toshihiko Shiraiwa, MD1,
  2. Hideaki Kaneto, MD, PHD1,
  3. Takeshi Miyatsuka, MD, PHD1,
  4. Ken Kato, MD1,
  5. Kaoru Yamamoto, MD1,
  6. Ayaha Kawashima, MD1,
  7. Tsutomu Kanda, MD, PHD2,
  8. Masaaki Suzuki, MD, PHD2,
  9. Eiichi Imano, MD, PHD2,
  10. Munehide Matsuhisa, MD, PHD1,
  11. Masatsugu Hori, MD, PHD1 and
  12. Yoshimitsu Yamasaki, MD, PHD1
  1. 1Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, Suita City, Osaka, Japan
  2. 2Department of Gastroenterology and Metabolic Disease, Osaka Prefectural General Hospital, Sumiyoshi-ku, Osaka, Japan
  1. Address correspondence to Yoshimitsu Yamasaki, MD, PhD, Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka, 565-0871, Japan. E-mail: yamasaki{at}medone.med.osaka-u.ac.jp
Diabetes Care 2005 Nov; 28(11): 2806-2807. https://doi.org/10.2337/diacare.28.11.2806
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

It is well known that postchallenge and postprandial hyperglycemia are related to the progression of diabetic macroangiopathy (1–6). However, there is little information regarding the association between diabetic microangiopathy and postprandial hyperglycemia in human subjects. In this study, we performed a follow-up study to elucidate the relationship between diabetic retinopathy and postprandial glycemia or insulinemia.

We recruited 151 Japanese patients with type 2 diabetes (74 men, aged 58.1 ± 10.2 years, and 77 women, aged 57.9 ± 9.2 years) who were admitted to Osaka Prefectural General Hospital between 1 January 1995 and 31 December 1999. The mean duration of diabetes of these patients was 7.4 ± 6.7 years. The mean BMI and HbA1c (A1C) were 25.7 ± 4.4 kg/m2 and 8.15 ± 1.51%, respectively. Eighty-three patients were treated with diet alone and 65 with oral hypoglycemic agents. Two to 4 days before admission, patients were given an oral glucose load of 75 g and postchallenge plasma glucose and insulin levels were determined 2 h later. Within 2–4 days after admission, postprandial plasma glucose and insulin levels were determined 2 h after the intake of an isocaloric mixed breakfast (10 kcal/kg body wt; 57% carbohydrate, 15% fat, and 28% protein), representative of a standard Japanese breakfast. Within a week after admission, retinopathy was assessed through dilated pupils by ophthalmologists. One hundred twenty-one subjects showed no evidence of diabetic retinopathy, 23 simple diabetic retinopathy, and 7 preproliferative retinopathy or proliferative retinopathy. After discharge from the hospital, subjects were followed prospectively for 5.0 ± 1.5 years.

During the follow-up periods, diabetic retinopathy worsened in 34 patients. Since A1C, postprandial plasma glucose and insulin, postchallenge plasma glucose and insulin, fasting plasma glucose and insulin, and duration of diabetes are closely linked, we performed multiple logistic model analyses, including sex, smoking, blood pressure, and serum lipid profile, to identify the independent and important predictors of the progression of diabetic retinopathy. Also, it is noted that in multiple regression analyses, the significance of several factors can be lost when there is a very close correlation among these several factors in addition to another factor having a stronger correlation. Postprandial plasma glucose levels (odds ratio 1.008, P = 0.016) correlated with the progression of diabetic retinopathy, and the significance in correlation between A1C levels and the progression of retinopathy was lost in our multiple regression analyses. These results indicate that postprandial hyperglycemia is a stronger predictor of the progression of diabetic retinopathy than A1C in Japanese type 2 diabetic patients. In addition, postprandial plasma insulin levels independently correlated with the progression of diabetic retinopathy (0.918, P < 0.0001) (Fig. 1). Thus, we assume that the control of excessive glucose excursions, especially in the postprandial state, may provide clinical benefit on not only carotid atherosclerosis but also diabetic retinopathy (7).

Figure 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1—

Effects of 2-h postprandial insulin and glucose concentrations on the progression of diabetic retinopathy during a 5-year follow-up period according to tertiles of 2-h postprandial insulin and glucose concentrations.

Footnotes

  • DIABETES CARE

References

  1. ↵
    Bonora E, Kiechi S, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M, Willeit J: Impaired glucose tolerance, type II diabetes and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia 43:156–164, 2000
    OpenUrlCrossRefPubMedWeb of Science
  2. The DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405, 2001
    OpenUrlCrossRefPubMedWeb of Science
  3. Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL: Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 24:1397–1402, 2001
    OpenUrlAbstract/FREE Full Text
  4. The DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617–621, 1999
    OpenUrlCrossRefPubMedWeb of Science
  5. Bonora E, Muggeo M: Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44:2107–2114, 2001
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, the STOP-NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486–494, 2003
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Katherine Esposito, Dario Giugliano, Francesco Nappo, Raffaele Marfella, the Campanian Postprandial Hyperglycemia Study Group: Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 110:214–219, 2004
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Diabetes Care: 28 (11)

In this Issue

November 2005, 28(11)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Postprandial Hyperglycemia Is a Better Predictor of the Progression of Diabetic Retinopathy Than HbA1c in Japanese Type 2 Diabetic Patients
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Postprandial Hyperglycemia Is a Better Predictor of the Progression of Diabetic Retinopathy Than HbA1c in Japanese Type 2 Diabetic Patients
Toshihiko Shiraiwa, Hideaki Kaneto, Takeshi Miyatsuka, Ken Kato, Kaoru Yamamoto, Ayaha Kawashima, Tsutomu Kanda, Masaaki Suzuki, Eiichi Imano, Munehide Matsuhisa, Masatsugu Hori, Yoshimitsu Yamasaki
Diabetes Care Nov 2005, 28 (11) 2806-2807; DOI: 10.2337/diacare.28.11.2806

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Postprandial Hyperglycemia Is a Better Predictor of the Progression of Diabetic Retinopathy Than HbA1c in Japanese Type 2 Diabetic Patients
Toshihiko Shiraiwa, Hideaki Kaneto, Takeshi Miyatsuka, Ken Kato, Kaoru Yamamoto, Ayaha Kawashima, Tsutomu Kanda, Masaaki Suzuki, Eiichi Imano, Munehide Matsuhisa, Masatsugu Hori, Yoshimitsu Yamasaki
Diabetes Care Nov 2005, 28 (11) 2806-2807; DOI: 10.2337/diacare.28.11.2806
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.